Prognostic significance of E-cadherin and β-catenin in resected stage I non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 24, Issue 3, 2003, Pages 441-449

  Choi, Yong Soo ^a   Shim, Young Mog ^a   Kim, Sang Hui ^b   Son, Dae Soon ^b   Lee, Hye Sook ^b   Kim, Gou Young ^a   Han, Joungho ^a   Kim, Jhingook ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Catenin; E cadherin; Immunohistochemistry; Lung cancer; Tissue microarray

Indexed keywords

BETA CATENIN; UVOMORULIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CYTOSKELETAL PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROTEIN ARRAY ANALYSIS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042762970     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(03)00308-7     Document Type: Article

References (25)

1. Devesa S.S., Blot W.J., Stone B.J., Miller B.A., Tarone R.E., Fraumeni J.F. Jr. Recent cancer trends in the United States. J Natl Cancer Inst. 87:1995;175-182.
2. Mountain C.F. Revisions in the international staging system for lung cancer. Chest. 111:1997;1711-1717.
3. Hirsch F.R., Franklin W.A., Gazdar A., Bunn P.A. Jr. Early detection in lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res. 7:2001;5-22.
4. Menger M.D., Vollmar B. Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg. 83:1996;588-601.
5. Kadowaki T., Shiozaki H., Inoue M., Tamura S., Oka H., Doki Y., Iihara K., Matsui S., Iwazawa T., Nagafuchi A. E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res. 54:1994;291-296.
6. Matsuura K., Kawanishi J., Fujii S., Imamura M., Hirano S., Takeichi M., Niitsu Y. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer. 66:1992;1122-1130.
7. Hiscox S., Jiang W.G. Expression of E-cadherin, alpha, beta, and gamma-catenin in human colorectal cancer. Anticancer Res. 17:1997;1349-1354.
8. Ihara A., Koizumi H., Hashizume R., Uchikoshi T. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology. 23:1996;1441-1447.
9. Cheng L., Nagabhushan M., Pretlow T.P., Amini S.B., Pretlow T.G. Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol. 48:1996;1375-1380.
10. Liu D., Huang C., Kameyama K., Hayashi E., Yamauchi A., Kobayashi S., Yokomise H. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg. 71:2001;949-955.
11. Kase S., Sugio K., Yamazaki K., Okamoto T., Yano T., Sugimachi K. Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res. 6:2000;4789-4796.
12. Wijnhoven B.P.L., Dinjens W.N.M., Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 87:2000;992-1005.
13. Shiozaki H., Tahara H., Oka H. Expression of immuno-reactive E-cadherin adhesion molecules in human cancers. Am J Pathol. 139:1991;17-23.
14. Shimoyama Y., Hironashi S. Expression of E- and P-cadherin in gastric carcinoma. Cancer Res. 51:1991;2185-2192.
15. Hoos A., Urist M.J., Stojadinovic A., Mastorides S., Dudas M.E., Leung D.H., Kuo D., Brennan M.F., Lewis J.J., Cordon-Cardo C. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol. 158:2001;1245-1251.
16. Hidaka N., Nagao T., Asoh A., Kondo Y., Nagao K. Expression of Ecadherin α-catenin, β-catenin, γ-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. Mod Pathol. 11:1998;1039-1045.
17. De Leeuw W.J.F., Berx G., Vos C.B.J., Peterse J.L., Van de Vijver M.J., Litvinov S., Van Roy F., Cornelisse C.J., Cleton-Jansen A.M. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol. 183:1997;404-411.
18. Nuruki K., Toyoyama H., Ueno S., Hamanoue M., Tanabe G., Aikou T., Ozawa M. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas. Oncol Rep. 5:1998;1109-1114.
19. Xiangming C., Hokita S., Nuruki K., Toyoyama H., Tanabe G., Baba M., Takao S., Aikou T. The expression of cadherin-catenin complex in association with the clinicopathological features of early gastric cancer. Surg Today. 28:1998;587-594.
20. Pirinen R.T., Hirvikoski P., Johansson R.T., Hollmen S., Kosma V.M. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol. 54:2001;391-395.
21. Wu H., Lotan R., Menter D., Lippman S.M., Xu X.C. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res. 20:2000;1385-1390.
22. Kimura K, Endo Y, Yonemyra, Heizmann CW, Schafer BW, Watanabe Y, Sasaki T. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 2000;16:1125-1131.
23. Pantel K., Passlick B., Vogt J., Stosiek P., Angstwurm M., Seen-Hibler R., Haussinger K., Thetter O., Izbicki J.R., Riethmuller G. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol. 16:1998;1407-1413.
24. Sato G., Saijo Y., Uchiyama B., Kumano N., Sugawara S., Fujimura S., Sato M., Sagawa M., Ohkuda K., Koike K., Minami Y., Satoh K., Nukiwa T. Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinoma. J Clin Oncol. 17:1999;2721-2727.
25. Herbst R.S., Yano S., Kuniyasu H., Khuri F.R., Bucana C.D., Guo F., Liu D., Kemp B., Lee J.J., Hong W.K., Fidler I.J. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res. 6:2000;790-797.